National Cancer Institute
The National Cancer Institute (NCI), a prominent entity in cancer research and treatment, is headquartered in Egypt (EG) and serves as a leading institution in the Middle East and North Africa. Founded in 1969, the NCI has made significant strides in oncology, focusing on cancer prevention, diagnosis, and therapy. As a key player in the healthcare industry, the NCI offers a range of services, including advanced cancer treatment, clinical trials, and educational programmes aimed at improving patient outcomes. Its commitment to research and innovation has positioned it as a trusted authority in cancer care, contributing to notable advancements in the field. With a reputation for excellence, the NCI continues to play a vital role in the fight against cancer, making it a cornerstone of the Egyptian healthcare landscape.
DitchCarbon Score
How does National Cancer Institute's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Transport Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
National Cancer Institute's score of 20 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
National Cancer Institute's reported carbon emissions
The National Cancer Institute (NCI), headquartered in EG, currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions data. Additionally, there are no documented reduction targets or climate pledges associated with the NCI at this time. As a result, the NCI's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organization. Without specific emissions figures or reduction strategies, it is challenging to assess their environmental impact or commitment to sustainability. In the broader context, organisations in the healthcare sector are increasingly recognising the importance of addressing climate change and reducing carbon footprints, but specific actions and commitments from the NCI are currently not available.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
National Cancer Institute is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
